7008 Background: Cancer patients are often hospitalized with complications from cancer and cancer treatment. Many experience a decline in physical functioning which likely contributes to increased length of stay (LOS) and excess days, increased readmissions and decreased patient experience. We aimed to determine whether a mobility program project would improve quality of care and decrease healthcare utilization. Methods: We implemented a mobility aide program on an oncology unit in a large academic medical center between April 2, 2019 to December 31, 2019. The program consisted of nursing evaluation using the Activity Measure for Postacute Care (AMPAC), an ordinal scale ranging from bed rest to ambulating ≥250 feet, was used to quantify mobility. Plan of care was determined in a multidisciplinary manner with physical therapy (PT), nursing and a mobility aide, a medical assistant with enhanced rehabilitation training. Patients were then mobilized two times per day seven days a week. Using descriptive statistics we evaluated the programs impact on excess days, readmissions, changes in mobility and patient experience as measured by Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) during this time period compared to the 6 month interval prior to implementation. Results: During the study interval, 988 patients were admitted and received the mobility program. There was a 6% reduction in excess days (p = 0.04). Similarly, readmission rates decreased from 25% to 19% (p = 0.03). Overall 76% of patients wither maintained or improved their mobility score. During this time period HCAHPS scores (willingness to recommend hospital) increased from 63% at baseline to 91% (p = 0.01). Conclusions: Use of this mobility program resulted in a significant decrease in healthcare utilization and improvement in patient experience. This demonstrates that non-PT professionals can mobilize hospitalized cancer patients decreasing the burden of PT and nursing resources. Future work will evaluate the sustainability of the program and evaluate association with healthcare costs.
557 Introduction: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is an important clinical event that needs to be accurately reported. The Agency for Healthcare Research and Quality (AHRQ) has categorized VTE as a reportable patient safety indicator (PSI) and has distributed a software package for recording events such as VTE based upon diagnosis codes. At our institution, there was concern that VTEs identified by this software method may be over estimating the actual number. Objective: To verify the cases of VTE as identified by AHRQ methodology through a review of the medical record for each event reported. Methods: Through a review of the electronic medical record (EMR), the events recorded as a VTE by PSI software over a 7 month period from November 2008 to May 2009 were further characterized into categories of acute, remote or age indeterminate DVTs and were distinguished from events that were either isolated superficial vein thrombosis (SVT) or that were not VTE at all. Discharge summaries, hospital notes, operative reports and imaging reports were used to verify identified cases of VTE. VTE occurrences were grouped by the month of discharge of the patient. The PSI software utilized diagnosis codes that have been abstracted for a patient's hospitalization based upon physician documentation. Results: 437 events were recorded as VTE over a 7 month period. 59 cases (13.5%) were incorrectly coded as VTE. 35 cases (8.0%) were superficial vein thrombosis mistakenly classified as DVT. 12 cases (2.7%) had remote or age indeterminate DVTs. 12 cases (2.7%) cases had no VTE and were considered further abstraction errors. After interim reporting of the first 4 months of VTE data, vascular laboratory study reports were amended so that superficial vein thrombosis would no longer be identified by this terminology and would subsequently be classified as superficial vein thrombophlebitis. The last three months of data collection had 9 cases (4.7%) incorrectly identified as DVTs that were actually SVTs versus 26 cases (10.6%) prior to implementation of the nomenclature change. Conclusion: Hospitals must be aware of reporting practices in their own institution as national protocols may not completely depict individual hospital occurrences. Careful attention to the manner in which the medical record reflects events can make substantial difference in accounting of VTE occurrence. Because of the lack of specificity of current diagnosis coding guidelines, an appropriate medical term was not sufficient for medical record abstractors to categorize an event correctly in this study. As hospitals become monitored for quality of care with these methodologies, the accuracy of reporting becomes paramount. Disclosures: No relevant conflicts of interest to declare.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.